Juneyao Health Officially Transforms into Probiotics Industry

Under the influence of the recurring Covid-19 pandemic and rising raw material prices, both revenue and net profit of Juneyao Health declined to a certain extent in the first quarter of this year. However, the “second growth curve” of Juneyao’s probiotics business has entered the emergence period and started to contribute to revenue steadily. This year, Juneyao Health further clarified its mission of “becoming an expert in internal micro-ecology” and made probiotics and postbiotics as the two major development categories. Moreover, Juneyao Health is still extending its probiotic industrial chain through acquisition. (Source: 163.com)

Visit HPA-China’s Information Hub, CLICK HERE